Literature DB >> 12149489

High mobility group box chromosomal protein 1 (HMGB1) is an antibacterial factor produced by the human adenoid.

Cecilia K Zetterström1, Tomas Bergman, Britta Rynnel-Dagöö, Helena Erlandsson Harris, Olle Soder, Ulf Andersson, Hans G Boman.   

Abstract

Antibacterial factors were purified from human adenoid glands by tissue extraction and consecutive steps of reversed-phase chromatography and assayed for bactericidal activity against the airway pathogen Moraxella catarrhalis and also Escherichia coli and Bacillus megaterium. One of the most active components isolated from adenoids was identified by N-terminal sequence analysis and mass spectrometry as high mobility group box chromosomal protein 1 (HMGB1). This novel finding was further substantiated by Western blot analysis, demonstrating a protein of expected size reactive with HMGB1 antiserum. Local synthesis was confirmed by reverse-transcriptase PCR and in situ hybridization. Adenoid-derived HMGB1 and recombinant HMGB1 revealed comparable antibacterial activity at high rate. More than 95% of bacteria were eradicated within 5 min by HMGB1 in the cultures. Secretion from the adenoid gland surface was also demonstrated to contain antibacterial activity, mainly mediated by alpha-defensins, but not by HMGB1. We conclude that HMGB1, produced and stored intracellularly in the adenoid gland, contributes to the local antibacterial barrier defense system in the upper respiratory tract.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12149489     DOI: 10.1203/00006450-200208000-00004

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  21 in total

Review 1.  The many faces of HMGB1: molecular structure-functional activity in inflammation, apoptosis, and chemotaxis.

Authors:  Huan Yang; Daniel J Antoine; Ulf Andersson; Kevin J Tracey
Journal:  J Leukoc Biol       Date:  2013-02-27       Impact factor: 4.962

2.  Ligands of the receptor for advanced glycation end products, including high-mobility group box 1, limit bacterial dissemination during Escherichia coli peritonitis.

Authors:  Marieke A D van Zoelen; Ahmed Achouiti; Ann-Marie Schmidt; Huan Yang; Sandrine Florquin; Kevin J Tracey; Tom van der Poll
Journal:  Crit Care Med       Date:  2010-06       Impact factor: 7.598

3.  High Mobility Group Protein 1 Reverses Immune System Paralysis in Late-Phase Sepsis.

Authors:  Qing-Yang Liu; Yue-Xin Wang; Zong-Sheng Wu; Zhen-Wei Shi; Xu Wu; Xin Chen; Zhao Yang; Kai-Zhi Xu
Journal:  Infect Immun       Date:  2018-08-22       Impact factor: 3.441

4.  TLR activation regulates damage-associated molecular pattern isoforms released during pyroptosis.

Authors:  Sanna Nyström; Daniel J Antoine; Peter Lundbäck; John G Lock; Andreia F Nita; Kari Högstrand; Alf Grandien; Helena Erlandsson-Harris; Ulf Andersson; Steven E Applequist
Journal:  EMBO J       Date:  2012-12-07       Impact factor: 11.598

Review 5.  High-mobility group box 1 (HMGB1) in childhood: from bench to bedside.

Authors:  Valeria Chirico; Antonio Lacquaniti; Vincenzo Salpietro; Caterina Munafò; Maria Pia Calabrò; Michele Buemi; Teresa Arrigo; Carmelo Salpietro
Journal:  Eur J Pediatr       Date:  2014-05-09       Impact factor: 3.183

6.  High Mobility Group-Box 1 (HMGB1) levels are increased in amniotic fluid of women with intra-amniotic inflammation-determined preterm birth, and the source may be the damaged fetal membranes.

Authors:  Margaret A Baumbusch; Catalin S Buhimschi; Emily A Oliver; Guomao Zhao; Stephen Thung; Kara Rood; Irina A Buhimschi
Journal:  Cytokine       Date:  2016-03-05       Impact factor: 3.861

Review 7.  Alarmins link neutrophils and dendritic cells.

Authors:  De Yang; Gonzalo de la Rosa; Poonam Tewary; Joost J Oppenheim
Journal:  Trends Immunol       Date:  2009-08-21       Impact factor: 16.687

8.  Antimicrobial activity of high-mobility-group box 2: a new function to a well-known protein.

Authors:  Robert Küchler; Bjoern O Schroeder; Simon U Jaeger; Eduard F Stange; Jan Wehkamp
Journal:  Antimicrob Agents Chemother       Date:  2013-07-22       Impact factor: 5.191

Review 9.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

10.  Amino acid residues 201-205 in C-terminal acidic tail region plays a crucial role in antibacterial activity of HMGB1.

Authors:  Wei Gong; Yuan Li; Fan Chao; Gang Huang; Fengtian He
Journal:  J Biomed Sci       Date:  2009-09-14       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.